Client News

Interactive Strength Inc. (Nasdaq:TRNR) Drives CLMBR Growth With New Gold’s Gym Texas Installations Following the Six-Figure Order From Gold’s Gym SoCal

Gold’s Gym is installing multiple CLMBRs in three Central Texas locations initially and there is a potential of 58 total locations in Texas Gold’s Gym SoCal is installing multiple CLMBRs in each of its 23 locations in California There are more than 600 locations in the overall Gold’s Gym system AUSTIN, TX / ACCESSWIRE / […]

Longeveron® (NASDAQ: LGVN) Announces U.S. FDA Grants Fast Track Designation for Lomecel-B™ for the Treatment of Mild Alzheimer’s Disease

– FDA designation enables expedited clinical development and regulatory review timelines for Lomecel-B™ – – Second designation received for Lomecel-B™ for the treatment of mild Alzheimer’s Disease after Regenerative Medicine Advanced Therapeutics (RMAT) Designation announced on July 9, 2024 – – Phase 2a Lomecel-B™ data in mild Alzheimer’s Disease selected for Featured Research Session oral presentation and poster […]

Amesite (NASDAQ: AMST) Launches PREACTO™ App in Beta to Power Safety and Security at Home, Work, School and in Public Venues

Collaboration with Global Active Shooter Expert Chris Grollnek to Drive Awareness and Usage DETROIT, July 16, 2024 (GLOBE NEWSWIRE) — Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence (AI) software company offering a cloud-based learning platform for business and education markets, announced today that the beta registration is now available for PREACTO™, an innovative and […]

Amesite (NASDAQ:AMST) Opens Enrollment for AI Amesite Explorer Seminars for College-Bound High School Students

Company’s High-Touch, Bespoke High-Touch, High School Programs Enable Students to Access Top Faculty Directly, a Unique Offering in $115B Industry DETROIT, July 15, 2024 (GLOBE NEWSWIRE) — Amesite Inc. (NASDAQ:AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, announced today the formation of Amesite Explorer Seminar “AI for […]

A Single Drug Against Multiple Respiratory Virus Infections – COVID, RSV, Influenza, Bird Flu – Planning Next Phase of Clinical Trials, Says NanoViricides (NYSE American:NNVC)

SHELTON, CT / ACCESSWIRE / July 11, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage global leader in broad-spectrum antiviral nanomedicines, discusses its development program for NV-387, a single drug that has shown activity against many respiratory viral infections in animal models, enabling human clinical trials for a number of indications. There are […]

CDTG (NASDAQ:CDTG): High-growth China based wastewater treatment and technology company poised for rapid expansion. The market size of Chinese rural sewage treatment is expected to reach $30.0 billion by 2030.

OVERVIEW CDT Environmental Technology (NASDAQ:CDTG) is a China-based wastewater treatment company that manufactures and operates sewage treatment systems and septic tank treatment services in both rural and urban areas. In the rural sewage treatment business, the company sells complete sewage treatment systems, constructs rural sewage treatment plants, provides installation services, and offers ongoing operation and […]

Amesite (NASDAQ: AMST) Announces AI-Powered Document Storage and Study Tools on NurseMagic™ App to Power Instantaneous Training for Nurses and Nursing Students

NurseMagic’s Library Function Enables Nurses to Upload and Transcribe Video and Audio Files and Create Study Materials to Enhance Work and School Performance DETROIT, July 11, 2024 (GLOBE NEWSWIRE) — Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, announced that its NurseMagicTM app now […]

Longeveron® (NASDAQ: LGVN) Announces U.S. FDA Grants Lomecel-B™ Regenerative Medicine Advanced Therapy (RMAT) Designation for the Treatment of Mild Alzheimer’s Disease

– Lomecel-B™ appears to be the first cellular therapeutic candidate to receive RMAT designation for Alzheimer’s Disease MIAMI, July 10, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for certain life-threatening and chronic aging-related conditions, today announced that the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.